| Date | Title | Description |
| 10.08.2026 | M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform | What You Should Know
Digital healthcare leader iRhythm Holdings, Inc. has entered into a definitive agreement to acquire Vital Connect, Inc. for approximately $287.5M.
The transaction consideration consists of $237.5 million in cash (funded... |
| 16.06.2026 | iRhythm discloses cyber incident, says no impact on device systems, patient safety | June 15 : iRhythm Holdings on Monday reported unauthorized activity involving data maintained on some third-party applications last week, but said it has not identified any impact on products, patient safety or medical device systems from t... |
| 01.08.2025 | iRhythm, Lucem Health Partner to Detect Arrhythmia with Predictive AI | What You Should Know:
– iRhythm Technologies, a digital health leader focused on detecting, predicting, and preventing disease announced a strategic partnership with Lucem Health, an AI-driven early disease detection.
– The strategic collab... |
| 13.03.2024 | FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of iRhythm Technologies, Inc. - IRTC | - |
| 13.03.2024 | Lost Money on iRhythm Technologies, Inc.(IRTC)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky | - |
| 13.03.2024 | Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC) | - |
| 13.03.2024 | IRHYTHM SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC | NEW ORLEANS, March 12, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 8, 2024 to file lead plaintiff applications in a securities class action lawsuit against iRhyt... |
| 13.03.2024 | IRTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | - |
| 12.03.2024 | Lost Money on iRhythm Technologies, Inc.(IRTC)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm | - |
| 12.03.2024 | IRHYTHM SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC | - |
| 10.03.2024 | ROSEN, NATIONAL TRIAL LAWYERS, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRTC | NEW YORK, March 10, 2024 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC) between January 11, 2022 and May 30, 2023, both dates inclu... |
| 10.03.2024 | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, and Amplitude and Encourages Investors to Contact the Firm | - |
| 10.03.2024 | ROSEN, NATIONAL TRIAL LAWYERS, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRTC | - |
| 08.03.2024 | iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes | SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced to... |
| 08.03.2024 | iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes | - |
| 08.03.2024 | Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors | SCOTTSDALE, Ariz., March 08, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, a leading materials science platform that supports the design, development and manufacturing of life saving implants, today announced the appointments of ... |
| 07.03.2024 | DEADLINE ALERT: Bernstein Liebhard LLP Reminds iRhythm Technologies, Inc. Investors of Upcoming Deadline | - |
| 07.03.2024 | SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC | - |
| 07.03.2024 | SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm | - |
| 06.03.2024 | IRTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | - |
| 06.03.2024 | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm | - |
| 06.03.2024 | ROSEN, NATIONAL TRIAL LAWYERS, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRTC | - |
| 05.03.2024 | IRHYTHM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains... | - |
| 05.03.2024 | Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc. (IRTC) Shareholders | - |
| 05.03.2024 | Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC) | - |
| 04.03.2024 | iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029 | - |
| 26.09.2023 | iRhythm Launches Wearable ECG Heart Monitor | What You Should Know:
iRhythm Technologies, Inc. today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous monitoring (LTCM) service.
Zio monitor is iRhythm’s smallest, lightest and thinnest ... |
| 06.06.2023 |
iRhythm’s FDA warning letter details alleged violations and patient deaths | The iRhythm Zio AT [Image courtesy of iRhythm]An FDA warning letter made public today accused iRhythm Technologies (Nasdaq: IRTC) + of violations of the Federal Food, Drug, and Cosmetic Act’s rules for labeling, quality systems and medical ... |
| 10.08.2022 | Mawi launches a patch to track your heart health faster and in real time | If you’ve ever had the misfortune of needing continuous EKG monitoring, you’ve probably used a Holter monitor. It’s like carrying a 1980s walkman made of metal with a bunch of wires going from it to your chest. If that sounds uncomfortable,... |
| 04.08.2022 | iRhythm Technologies Announces Second Quarter 2022 Financial Results | SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months end... |
| 22.07.2022 | FDA Awards 510(k) Clearances for ZEUS System/Zio Watch | What You Should Know:
– Today, iRhythm (a digital health company) and Verily (Alphabet’s life sciences research organization) announced joint FDA 510(k) clearances for the ZEUS System and Zio Watch. Together they create an integrated, presc... |
| 17.01.2022 | How Will AI Continue to Shape Healthcare in 2022? 9 Predictions to Watch | Digital health executives share their predictions on how artificial intelligence (AI) will continue to shape the healthcare industry in 2022.
Diana Nole, EVP and GM of Healthcare at Nuance Communications, Inc.
AI will find more game-changin... |
| 04.11.2021 | iRhythm Technologies Announces Third Quarter 2021 Financial Results | SAN FRANCISCO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months en... |
| 11.09.2019 | iRhythm closes $115m offering | iRhythm Technologies (NSDQ:IRTC) said yesterday that it closed its underwritten public offering of common stock for gross proceeds exceeding $100 million.
The San Fransisco-based company said it offered nearly 1.6 million shares at $73 per ... |
| 20.04.2017 | Cardiac Insight raises $4.5M, wins FDA approval to launch wearable ECG sensor | Cardea Solo is about 4 inches long, 3 inches wide, and adheres directly to the skin for up to seven days. (Cardiac Insight Photo)
Consumer wearables, like smart watches and Fitbits, are becoming ever more popular. But wearable medical techn... |
| 02.01.2017 | Top predictions on tech in 2017 from Norwest Venture Partners | With a portfolio including blockbuster names like the ride-hailing service Uber and cardiac health technology developer iRhythm, Norwest Venture Partners‘ team has ranged far and wide through the tech landscape.
Here are their predictions f... |
| 20.10.2016 | iRhythm goes public with $107M IPO | iRhythm, the wearable heart monitor company that announced its intention to IPO last month, went public today and increased its share price and number of shares on offer, raising the value of its IPO from an expected $86 million to $107 mil... |
| 26.09.2016 | Zio patch maker iRhythm files for $86M IPO | iRhythm, maker of the wearable-and-wireless-but-not-connected Zio heart rate monitoring system, has filed with the SEC to raise up to $86 million in an initial public offering.
The Zio patch, iRhythm's sole product as of now, is a small wea... |
| 26.05.2016 | Kaiser Permanente Ventures senior managing director talks about his return (Q&A) | Sam Brasch has moved back to Kaiser Permanente Ventures, the investment arm of the Kaiser Permanente health system, this time as senior managing director. The move comes after a year of working with New Leaf Venture Partners, which invests ... |
| 29.04.2016 | Cardiac wearable developer closes Series C round to detect heart problems in young athletes | The company’s investors include Kirby Cramer, the former chairman of Sonosite; Dick Martin, the former CEO of Physio-Control; and WRF Capital, according to Xconomy.
Among the medical device businesses competing in this space are iRhythm Tec... |
| 30.11.2015 | Can remote monitoring flag patients with AFib better than checkups? Scripps clinical trial seeks answer | Scripps Translational Science Institute is collaborating with Aetna and Janssen Pharmaceuticals in a clinical trial to determine if remote monitoring using wearables can spot asymptomatic Atrial Fibrillation — a condition linked to more tha... |
| 05.05.2015 | Skyrocketing healthcare costs! | How is technology saving the day and changing healthcare tomorrow?
At Vator Splash Health 2015, held last February 12, 2015, Casper de Clercq of Norwest Venture Partners moderated the panel discussing the "Skyrocketing healthcare cost ... |
| 13.02.2015 | See how Vator Splash Health played out on Twitter!
Early-Stage Venture-Capital Investors
Early-Stage Venture-Capital Investors | Thank you to all of those who attended Vator Splash Health!
Vator held its first ever Splash Health event on Thursday, and it couldn't have gone better. Not only were the panelists, and all of our presenting companies great, but so were all... |
| 17.01.2015 | The biggest healthtech deals of 2014 | Categories include telemedicine, digital medical devices and personalized medicine
This month, in anticipation of Vator hosting its first ever Splash Health event on February 12th, we've been putting the spotlight on the healthtech space.
E... |
| 23.05.2014 | The Xconomy SF Six: Big Name Investors, Funding for Clarizen, and More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Here are the top six things we’re paying attention to in the San Francisco tech scene this week.
—iRhythm Technologies, maker of technology to improve the diagnosis of heart a... |
| 22.05.2014 | Cardiac patch to detect arrhythmias draws $17 million in Series E round | The U.S. Food and Drug Administration gave 510(k) clearance to iRhythm’s Zio Patch in 2009, and it was introduced commercially in 2011.
Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently dur... |
| 22.05.2014 | iRhythm raises $17M for its heart-sensing Zio patch | iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture Partners also participated in the round.... |
| 22.05.2014 | mHealth: iRhythm raises $17M for Zio wearable monitor | Remote monitoring startup iRhythm touted a new $17 million Series E funding round in support of its wearable devices, saying it plans to pursue efforts in commercialization, marketing and clinical studies.
The San Francisco company offers c... |
| 22.05.2014 | iRhythm Technologies Closes $17M Series E Financing | iRhythm Technologies, Inc., a San Francisco, CA-based healthcare information services company, closed a $17m Series E financing.
The round was led by Novo A/S, with participation from existing investor Norwest Venture Partners. In conjuncti... |
| 22.05.2014 | iRhythm Secures $17M in Series E |
SAN FRANCISCO, CA, Healthcare information services company, today announced that it closed a $17 million Series E financing led by Novo A/S.
>> Click here for more funding data on iRhythm
>> To export iRhythm funding data to... |
| 12.04.2013 | St. Jude-backed iRhythm Technologies raises another $16M for Zio wearable heart monitor | iRhythm Technologies said it closed a $16 million Series D round for its Zio wearable heart monitor, saying it plans to use the proceeds to further its commercial footprint and research & development efforts.
Led by Norwest Venture Part... |
| 10.04.2013 | iRhythm Secures $16M in Series D Funding |
SAN FRANCISCO, CA, Medical device, service and technology company that develops and markets simple, innovative diagnostic monitoring solutions, today announced that it closed $16 million in Series D venture financing.
>> Click here... |
| 10.04.2013 | iRhythm raises $16M for patch that stores heartbeat data to help spot arrhythmia | When it’s time to take off the patch, patients send it to iRhythm’s national clinical center for processing. The data is assembled into reports that are made available to physicians, but patients also get access to them.
The U.S. Food and D... |
| 10.04.2013 | iRhythm Technologies Closes $16M Series D Venture Financing | iRhythm Technologies, Inc., a San Francisco, CA-based medical device, service and technology company that develops and markets diagnostic monitoring solutions, closed a $16m Series D venture financing.
The round was led by Norwest Venture P... |
| 20.11.2012 | iRhythm Announces $1.5M Investment |
SAN FRANCISCO, CA, Medical device, service and technology company that develops and markets simple, innovative diagnostic monitoring solutions, today announced that the California HealthCare Foundation (CHCF) has made a $1.5 million inves... |
| 27.07.2012 | Patient illustrates how the iPhone and $1.99 could disrupt the medical device industry | Doctors wanting to determine a patient’s atrial fibrillation burden have a myriad of technologies at their disposal: 24-hour Holter monitors, 30-day event monitors that are triggered by an abnormal heart rhythm or by the patient themselves,... |
| 27.07.2012 | How the iPhone might disrupt the medical device industry | Doctors wanting to determine a patient’s atrial fibrillation burden have a myriad of technologies at their disposal: 24-hour Holter monitors, 30-day event monitors that are triggered by an abnormal heart rhythm or by the patient themselves,... |
| 06.10.2011 | The difficulties of atrial fibrillation | By Westby G. Fisher, MD, FACC
I am always amazed at the different ways atrial fibrillation can present: sometimes with rapid heart rates, other times slow; sometimes it’s continuous, other times intermittent; sometimes it occurs without sym... |
| 13.05.2011 | St. Jude Medical reinvests in iRhythm Technologies | A St. Jude Medical spokeswoman would not disclose how much St. Jude has invested, but did acknowledge that the year-long partnership ” so far it has been a positive relationship” for both companies.
“Over the last year, we have conducted a ... |
| 18.05.2010 | IRhythm Technologies Completes $10M Financing Round | iRhythm Technologies, Inc., a San Francisco, CA-based healthcare technology and service company, has completed a $10m private equity round of financing.
The round was led by St. Jude Medical (NYSE:STJ), with participation from existing inve... |
| 15.05.2009 | Cardiac monitor maker iRhythm looks to insiders for $6.5M | iRhythm Technologies, maker of a recently-launched cardiac monitoring device, has raised an additional $6.5 million in a first round of funding from existing investors, bringing the two-year-old round’s total to $19 million. Based in San Fr... |
| 08.02.2007 | IRhythm, cardiac monitoring device co., raises $12.5M | IRhythm Technologies, a secretive San Francisco start-up (no Web site) developing a cardiac-rhythm monitoring device, has raised $12.5 million in a first round of venture capital, according to PEHub.
Investos are Mohr Davidow Ventures and S... |
| - | Cardiac wearable developer closes Series C round to detect heart problems in young athletes | Cardiac Insight, a University of Washington spinoff, has closed a $2.5 million Series C round. The funding will be used to support the advancement of the handheld CardeaScreen ECG device — which it acquired through its purchase of Cardea As... |
| - | Patient illustrates how the iPhone and $1.99 could disrupt the medical device industry | Doctors wanting to determine a patient’s atrial fibrillation burden have a myriad of technologies at their disposal: 24-hour Holter monitors, 30-day event monitors that are triggered by an abnormal heart rhythm or by the patient themselves,... |
| - | Can remote monitoring flag patients with AFib better than checkups? Scripps clinical trial seeks answer | Scripps Translational Science Institute is collaborating with Aetna and Janssen Pharmaceuticals in a clinical trial to determine if remote monitoring using wearables can spot asymptomatic Atrial Fibrillation — a condition linked to more tha... |
| - | Cardiac patch to detect arrhythmias draws $17 million in Series E round | Cardiac rhythm diagnostics device maker iRhythm Technologies has raised $17 million, according to a company statement, as providers try to keep patients out of the hospital, but keep an eye on warning signs of worsening conditions. That tre... |
| - | St. Jude Medical reinvests in iRhythm Technologies | St. Jude Medical’s partnership with a California-based arrhythmia-diagnostic company seems to be going well enough that it recently poured more money into that startup.
In May 2010, the Little Canada, Minnesota-based company signed a co-bra... |
| - | iRhythm snags FDA approval for AFib characterization algorithm used in Verily’s wearable | On Friday, the Food and Drug Administration granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch.
The ZEUS (Zio ECG Utilization Software) S... |
| - | iRhythm raises $16M for patch that stores heartbeat data to help spot arrhythmia | A patch that acts as an electrocardiogram to record and store heartbeats for up to 14 days so it can be analyzed later for signs of arrhythmia has raised $16 million in a series D round. The cardiac rhythm diagnostics device is designed to ... |
| - | Kaiser Permanente Ventures senior managing director talks about his return (Q&A) | Sam Brasch has moved back to Kaiser Permanente Ventures, the investment arm of the Kaiser Permanente health system, this time as senior managing director. The move comes after a year of working with New Leaf Venture Partners, which invests ... |
